137 related articles for article (PubMed ID: 2032737)
1. Generation of monoclonal antibodies specific for ras p21 Glu-12 oncoproteins: detection in carcinogen-induced mammary carcinomas.
Garlick DS; Sukumar S; Barbacid M; Petit D; Hamer PJ; Leav I; Lavecchio JA; Trimpe KL; Carney WP
Hybridoma; 1991 Feb; 10(1):95-102. PubMed ID: 2032737
[TBL] [Abstract][Full Text] [Related]
2. Characterization of monoclonal antibody R256, specific for activated ras p21 with arginine at 12, and analysis of breast carcinoma of v-Harvey-ras transgenic mouse.
Pullano TG; Sinn E; Carney WP
Oncogene; 1989 Aug; 4(8):1003-8. PubMed ID: 2474786
[TBL] [Abstract][Full Text] [Related]
3. Characterization of monoclonal antibodies specific to the activated ras p21 with aspartic acid at position 13.
La Vecchio JA; Hamer PJ; Ng SC; Trimpe KL; Carney WP
Oncogene; 1990 Aug; 5(8):1173-8. PubMed ID: 2202949
[TBL] [Abstract][Full Text] [Related]
4. Activated Val-12 ras p21 in cell culture fluids and mouse plasma.
Hamer PJ; La Vecchio J; Ng S; DeLellis R; Wolfe H; Carney WP
Oncogene; 1991 Sep; 6(9):1609-15. PubMed ID: 1923528
[TBL] [Abstract][Full Text] [Related]
5. Production and characterization of anti-RAS p21 monoclonal antibodies.
Hamer PJ; Trimpe KL; Pullano T; Ng S; LaVecchio JA; Petit DA; DeLellis R; Wolfe H; Carney WP
Hybridoma; 1990 Dec; 9(6):573-87. PubMed ID: 2076896
[TBL] [Abstract][Full Text] [Related]
6. A monoclonal antibody reactive with an activated ras protein expressing valine at position 12.
Carney WP; Hamer P; Petit D; Wolfe H; Cooper G; Lefebvre M; Rabin H
J Cell Biochem; 1986; 32(3):207-14. PubMed ID: 3536974
[TBL] [Abstract][Full Text] [Related]
7. Involvement of ras oncogenes in the initiation of carcinogen-induced tumors.
Barbacid M
Princess Takamatsu Symp; 1986; 17():43-53. PubMed ID: 3332020
[TBL] [Abstract][Full Text] [Related]
8. Detection of activated Mr 21,000 protein, the product of ras oncogenes, using antibodies with specificity for amino acid 12.
Wong G; Arnheim N; Clark R; McCabe P; Innis M; Aldwin L; Nitecki D; McCormick F
Cancer Res; 1986 Dec; 46(12 Pt 1):6029-33. PubMed ID: 3490906
[TBL] [Abstract][Full Text] [Related]
9. Limonene chemoprevention of mammary carcinoma induction following direct in situ transfer of v-Ha-ras.
Gould MN; Moore CJ; Zhang R; Wang B; Kennan WS; Haag JD
Cancer Res; 1994 Jul; 54(13):3540-3. PubMed ID: 8012978
[TBL] [Abstract][Full Text] [Related]
10. N-nitroso-N-methylurea-induced mammary carcinogenesis: effect of prolactin on expression of Ia antigen by tumor cells.
Bernard DJ; Maurizis JC; Chassagne J; Chollet P; Plagne R
J Natl Cancer Inst; 1986 Jun; 76(6):1237-42. PubMed ID: 3012179
[TBL] [Abstract][Full Text] [Related]
11. Incidence of p53 and Ha-ras gene mutations in chemically induced rat mammary carcinomas.
Kito K; Kihana T; Sugita A; Murao S; Akehi S; Sato M; Tachibana M; Kimura S; Ueda N
Mol Carcinog; 1996 Oct; 17(2):78-83. PubMed ID: 8890956
[TBL] [Abstract][Full Text] [Related]
12. N-nitroso-N-methylurea-induced rat mammary tumors arise from cells with preexisting oncogenic Hras1 gene mutations.
Cha RS; Thilly WG; Zarbl H
Proc Natl Acad Sci U S A; 1994 Apr; 91(9):3749-53. PubMed ID: 8170982
[TBL] [Abstract][Full Text] [Related]
13. ras gene mutations are absent in NMU-induced mammary carcinomas from aging rats.
Thompson TA; Haag JD; Gould MN
Carcinogenesis; 2000 Oct; 21(10):1917-22. PubMed ID: 11023551
[TBL] [Abstract][Full Text] [Related]
14. Induction of mammary carcinomas in rats by nitroso-methylurea involves malignant activation of H-ras-1 locus by single point mutations.
Sukumar S; Notario V; Martin-Zanca D; Barbacid M
Nature; 1983 Dec 15-21; 306(5944):658-61. PubMed ID: 6318112
[TBL] [Abstract][Full Text] [Related]
15. Alterations in H-ras1 promoter conformation during N-nitroso-N-methylurea-induced mammary carcinogenesis and pregnancy.
Jin Z; Houle B; Mikheev AM; Cha RS; Zarbl H
Cancer Res; 1996 Nov; 56(21):4927-35. PubMed ID: 8895746
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of neu-related lipocalin (NRL) in neu-initiated but not ras or chemically initiated rat mammary carcinomas.
Stoesz SP; Gould MN
Oncogene; 1995 Dec; 11(11):2233-41. PubMed ID: 8570173
[TBL] [Abstract][Full Text] [Related]
17. Comparative immunohistochemical reactivity of monoclonal and polyclonal antibodies to H-ras p21 in normal and neoplastic tissues of rodents and humans.
Ward JM; Perantoni AO; Santos E
Oncogene; 1989 Feb; 4(2):203-13. PubMed ID: 2648257
[TBL] [Abstract][Full Text] [Related]
18. Reduction in the frequency of activated ras oncogenes in rat mammary carcinomas with increasing N-methyl-N-nitrosourea doses or increasing prolactin levels.
Zhang R; Haag JD; Gould MN
Cancer Res; 1990 Jul; 50(14):4286-90. PubMed ID: 2194653
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of potential oncogene alterations in the ENU1564 rat mammary tumor model.
Hal DG; Stoica G
Anticancer Res; 1994; 14(2A):481-7. PubMed ID: 7912494
[TBL] [Abstract][Full Text] [Related]
20. Direct mutagenesis of Ha-ras-1 oncogenes by N-nitroso-N-methylurea during initiation of mammary carcinogenesis in rats.
Zarbl H; Sukumar S; Arthur AV; Martin-Zanca D; Barbacid M
Nature; 1985 May 30-Jun 5; 315(6018):382-5. PubMed ID: 3923365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
